Your browser is no longer supported. Please, upgrade your browser.
SNY Sanofi weekly Stock Chart
SNY [NASD]
Sanofi
Index- P/E21.92 EPS (ttm)2.00 Insider Own16.40% Shs Outstand2.50B Perf Week2.79%
Market Cap109.79B Forward P/E12.51 EPS next Y3.50 Insider Trans0.00% Shs Float2.23B Perf Month4.11%
Income5.01B PEG2.81 EPS next Q0.74 Inst Own7.80% Short Float0.11% Perf Quarter-0.25%
Sales40.95B P/S2.68 EPS this Y15.50% Inst Trans0.87% Short Ratio1.73 Perf Half Y1.46%
Book/sh26.25 P/B1.67 EPS next Y8.12% ROA- Target Price52.00 Perf Year12.32%
Cash/sh- P/C- EPS next 5Y7.80% ROE- 52W Range39.48 - 45.62 Perf YTD0.99%
Dividend1.74 P/FCF- EPS past 5Y4.80% ROI5.00% 52W High-3.90% Beta0.60
Dividend %3.97% Quick Ratio- Sales past 5Y2.70% Gross Margin68.30% 52W Low11.04% ATR0.71
Employees104226 Current Ratio- Sales Q/Q7.20% Oper. Margin18.30% RSI (14)60.27 Volatility1.29% 1.10%
OptionableYes Debt/Eq- EPS Q/Q12.00% Profit Margin16.40% Rel Volume0.45 Prev Close44.15
ShortableYes LT Debt/Eq- EarningsJul 26 BMO Payout0.00% Avg Volume1.38M Price43.84
Recom1.50 SMA203.30% SMA503.92% SMA2001.52% Volume622,091 Change-0.70%
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Nov-15-17Upgrade Barclays Underweight → Equal Weight
Aug-30-17Upgrade HSBC Securities Reduce → Hold
May-11-17Downgrade Berenberg Buy → Hold
Apr-07-17Downgrade HSBC Securities Hold → Reduce
Apr-06-17Initiated Argus Buy $50
Mar-09-17Initiated Liberum Hold
Nov-07-16Initiated Goldman Neutral
Sep-23-16Initiated Piper Jaffray Neutral
Sep-15-16Resumed JP Morgan Underweight
Sep-13-16Upgrade Exane BNP Paribas Underperform → Neutral
Sep-08-16Upgrade Berenberg Hold → Buy
Jun-22-19 09:33AM  This would be the worst-case scenario for health stocks, according to UBS MarketWatch
Jun-21-19 04:15PM  Regeneron And Sanofi Tried To Outperform Themselves And Couldn't Investor's Business Daily
10:30AM  Sanofi/Regeneron's Asthma Candidate Meets Goal in Study Zacks
09:07AM  Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod Zacks
07:18AM  The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy Benzinga
Jun-20-19 09:47AM  The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens Zacks
Jun-19-19 08:09PM  Heres What Hedge Funds Think About Sanofi (SNY) Insider Monkey
10:52AM  Sanofi plans 466 job cuts as part of R&D reshuffle Reuters
09:07AM  Alphabet's Healthcare Push Gains Steam: Others Brace Up Zacks
Jun-18-19 10:54AM  Sanofi, Google Partner On Health Care-Focused Virtual Innovation Lab Benzinga
10:30AM  Sanofi Partners Google to Build Healthcare Innovation Lab Zacks
10:27AM  Protalix (PLX) Completes Enrollment in Fabry Disease Study Zacks
09:18AM  Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients Zacks
07:00AM  Market Morning: Trump Immigrant Roundup, Gold Threatens, Google Goes Pharma Market Exclusive
01:24AM  French drugmaker Sanofi, Google to use data tech for innovations Reuters
01:00AM  Google and Drugmaker Sanofi to Join Forces on Data Technologies Bloomberg
Jun-17-19 10:30PM  Sanofi/Google: pixel of health Financial Times
09:12AM  Regeneron (REGN) Presents Positive Data on Lymphoma Candidate Zacks
Jun-14-19 08:42AM  Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod Zacks
Jun-13-19 06:40AM  Does Sanofi (EPA:SAN) Create Value For Shareholders? Simply Wall St.
Jun-11-19 09:03AM  Lilly Announces Tradjenta Cardiovascular Outcome Study Data Zacks
07:00AM  Canadian employers underestimate the presence of chronic disease in the workforce CNW Group
Jun-10-19 12:34PM  Sanofi (SNY) in Focus: Stock Moves 5.5% Higher Zacks
Jun-07-19 12:25PM  Sanofi's Leadership Transition: What You Need To Know Benzinga +5.49%
11:53AM  New Sanofi CEO 2019: 8 Things to Know About Paul Hudson InvestorPlace
10:59AM  Sanofi Taps Novartis Executive as CEO in Race for New Drugs Bloomberg
10:21AM  Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache Zacks
09:09AM  Novartis Appoints New Pharma Unit Head, Gives Other Updates Zacks
07:24AM  The Daily Biotech Pulse: Vertex Bets Big On Gene-Editing Therapies, Sanofi Poaches Novartis For CEO Role, Relief In Europe for Endologix Benzinga
06:58AM  UPDATE 3-Drugmaker Sanofi hires Hudson from Novartis as CEO Reuters
04:40AM  UPDATE 1-European stocks head for best week in 2 months, Sanofi jumps Reuters
03:51AM  Sanofi appoints top Novartis executive as new chief Financial Times
03:33AM  European stocks recover after ECB disappointment Reuters
02:16AM  CORRECTED-UPDATE 2-Drugmaker Sanofi appoints Novartis' Hudson as CEO Reuters
01:16AM  Swiss drugmaker Novartis names new drug division head Reuters
Jun-06-19 03:09PM  Local biotech firm bought for up to $70M American City Business Journals
09:09AM  Was ASCO Quieter for Big Drug/Biotech Stocks This Year? Zacks
Jun-05-19 09:09AM  Glaxo's Nucala Gets CHMP Nod for 2 Self-Administered Options Zacks
Jun-04-19 11:52AM  Emergent (EBS) Wins HHS Contract to Supply VIGIV Product Zacks
11:50AM  Sanofi loses German patent case against Amgen over cholesterol drug Reuters
May-31-19 11:21AM  Small-Cap Biotechs Aim to Steal Spotlight at Cancer Meeting Bloomberg
May-30-19 08:28AM  Amarin Rises on Priority Review for Vascepa Label Expansion Zacks
May-29-19 10:52AM  BioMarin Announces Data on Hemophilia Candidate, Shares Fall Zacks
May-23-19 10:03AM  Alphabet to Aid Pharma Giants Enhance Clinical Trial Process Zacks
09:08AM  Lilly (LLY) Launches Half-Priced Version of Humalog Insulin Zacks
May-21-19 06:31AM  Is Sanofi (EPA:SAN) Trading At A 32% Discount? Simply Wall St.
May-16-19 08:20AM  Pfizer's Eczema Candidate Meets All Goals in Phase III Study Zacks
May-15-19 05:00PM  Sanofi oncology pipeline targeting various cancers highlighted at ASCO 2019 PR Newswire
08:04AM  Sanofi Joins Drugmakers' Bid to Treat Patients With Software Bloomberg
May-10-19 10:21AM  Inovio (INO) Q1 Earnings & Revenues Fall Short of Estimates Zacks
May-08-19 01:12PM  Sanofi Recognized by DiversityInc as a Top 50 Company PR Newswire
09:37AM  Here's the Bad News That Derailed Regeneron's Stock Motley Fool
08:45AM  Sanofi Announces Licensing of Dupixent® (dupilumab) in the EU for the Treatment of Severe Asthma With Type 2 Inflammation PR Newswire
May-07-19 11:52AM  Regeneron Pharmaceuticals Earnings: REGN Stock Drops on Q1 Miss InvestorPlace -5.28%
08:00AM  How To Trade Growth Stocks: The Easy Way To Check And Confirm Institutional Support Investor's Business Daily
May-06-19 04:15PM  A Single Rival Caused 2 Biopharma Stocks To Slip Here's Why Investor's Business Daily
09:21AM  The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo Zacks
May-03-19 03:41PM  Emergent (EBS) Earnings & Revenues Miss Estimates in Q1 Zacks
09:46AM  Drugmakers lobbying spending at 10-year high as Washington targets soaring prices MarketWatch
06:10AM  Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks
May-02-19 02:18PM  5 Biotech Stocks With Near-Term Catalysts Ahead Benzinga
10:00AM  Alnylam (ALNY) Reports Narrower-Than-Expected Loss in Q1 Zacks
08:16AM  The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data Benzinga
May-01-19 06:35PM  FDA approves Dengvaxia® for the prevention of dengue in individuals ages 9 through 16 living in U.S. endemic areas PR Newswire
09:28AM  What's in the Cards for Novavax (NVAX) This Earnings Season? Zacks
Apr-30-19 12:02PM  Sanofi: Annual General Meeting of April 30, 2019 GlobeNewswire
Apr-29-19 07:50PM  SoftBank Is Near $1 Billion Investment in Colombia's Rappi Bloomberg
Apr-27-19 11:44AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs Benzinga
Apr-26-19 08:09PM  U.S. FDA approves expanded label for Regeneron/Sanofi's cholesterol drug Reuters
04:33PM  Sanofi (SNY) Q1 2019 Earnings Call Transcript Motley Fool
02:04PM  BioMarin (BMRN) Shares Down Despite Q1 Earnings & Sales Beat Zacks
09:29AM  Sanofi (SNY) Q1 Earnings Top, Genzyme & Vaccines Drive Sales Zacks
08:05AM  Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER PR Newswire
05:08AM  Sanofi: 1Q Earnings Snapshot Associated Press
03:57AM  Sanofi Profit Jumps on Sales of Vaccines and a Rising New Drug Bloomberg
03:20AM  AstraZeneca Cancer Drug Sales Fuel Profit Beating Estimates Bloomberg
02:18AM  Genzyme and vaccines push up Sanofi's first-quarter results Reuters
Apr-22-19 01:54PM  This Is Why You Shouldnt Count Regeneron Stock Out InvestorPlace
Apr-17-19 11:01AM  Emergent's (EBS) Chikungunya Vaccine Positive in Phase II Study Zacks
10:11AM  Sanofi Named One of America's Best Employers by Forbes PR Newswire
08:08AM  Boehringer's operating income flat as integration costs weigh Reuters
07:00AM  World Hemophilia Day: Sanofi Genzyme Donation Impacts Patients Across the Globe PR Newswire
06:44AM  Boehringer's operating income flat as integration costs weigh Reuters
Apr-16-19 06:51AM  Does Sanofi (EPA:SAN) Have A Good P/E Ratio? Simply Wall St.
Apr-12-19 10:13AM  Opiant CEO, creator of Narcan, weighs in on opioid overdose crisis Yahoo Finance Video
Apr-11-19 02:43PM  Health Canada issues Notice of Compliance with Conditions (NOC/c) for LibtayoTM (cemiplimab), the first and only biologic for the treatment of advanced cutaneous squamous cell carcinoma (CSCC) CNW Group
Apr-10-19 10:03AM  3 Biotech Stocks That Doubled After Hitting Bottom in 2018 Motley Fool
09:24AM  Sanofi sets a fixed price of insulin at $99 per month for some patients CNBC
05:04AM  Sanofi to cut U.S. insulin costs for some patients to $99 per month Reuters
05:00AM  Sanofi to cut U.S. insulin costs for some patients to $99 per month Reuters
05:00AM  Sanofi provides unprecedented access to its insulins for one set monthly price PR Newswire
Apr-09-19 10:59AM  Emergent's (EBS) Strong Vaccine Portfolio to Fuel Growth Zacks
09:03AM  Regeneron, Alnylam Extend Collaboration for RNAi Therapeutics Zacks
Apr-08-19 09:10AM  Alnylam trades partner Sanofi for Regeneron in $800M deal American City Business Journals
Apr-02-19 10:51AM  Inovio Closes Enrollment in Brain Cancer Study Before Time Zacks
Apr-01-19 10:41AM  Merck KgaA's (MKGAF) MS Drug Mavenclad Gets FDA Approval Zacks
01:31AM  Sanofi: Availability of the Pre-quarterly Results Communication GlobeNewswire
Mar-29-19 12:45PM  Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates Benzinga
08:55AM  CDC: 44 States Still Reporting High Flu Activity Benzinga
Mar-28-19 10:43AM  AstraZeneca's Forxiga Gets Nod in Japan for Type I Diabetes Zacks
Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia in adults and children; and Cablivi to treat acquired thrombotic thrombocytopenic purpura in adults. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, for hematologic malignancies; and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. The company has an alliance with Verily Life Sciences LLC. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerMar 08Sale412.17131,11554,041,31620,723,717Mar 12 08:19 PM
Sanofi10% OwnerSep 06Sale406.68104,55242,519,24923,654,384Sep 10 05:01 PM